Search research articles
Contact Us
Filters
Showing results (421-430 of 493) with videos related to
Page
of 50
Sort By:
Genome Medicine
|
November 24, 2016
High-specificity bioinformatics framework for epigenomic profiling of discordant twins reveals specific and shared markers for ACPA and ACPA-positive rheumatoid arthritis
David Gomez-Cabrero, Malin Almgren, Louise K Sjöholm, et al.
Journal of Proteome Research
|
February 7, 2025
TIMS<sup>2</sup>Rescore: A Data Dependent Acquisition-Parallel Accumulation and Serial Fragmentation-Optimized Data-Driven Rescoring Pipeline Based on MS<sup>2</sup>Rescore
Arthur Declercq, Robbe Devreese, Jonas Scheid, et al.
Haematologica
|
April 6, 2023
Gene therapy restores the transcriptional program of hematopoietic stem cells in Fanconi anemia
Miren Lasaga, Paula Río, Amaia Vilas-Zornoza, et al.
Journal of Geriatric Oncology
|
November 30, 2024
Real-world data on the clinical features, therapy patterns, and outcomes of older adults with diffuse large B-cell lymphoma in Latin America: A study from the Grupo de Estudio Latinoamericano de Linfoproliferativos (GELL)
Myrna Candelaria, Luis Villela, Luis F Oñate-Ocana, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie
|
May 11, 2022
Resuscitative endovascular balloon occlusion of the aorta in Canada: a context-specific position paper from the Canadian Collaborative for Urgent Care Surgery (CANUCS)
Nori L Bradley, W Robert Leeper, Derek Roberts, et al.
Molecular Pharmacology
|
February 20, 2016
Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model
Shannon Dallas, Laurent Salphati, David Gomez-Zepeda, et al.
The Lancet. Gastroenterology & Hepatology
|
February 16, 2024
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study
Thomas Yau, Ahmed Kaseb, Ann-Lii Cheng, et al.
The Lancet. Oncology
|
July 7, 2022
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial
Robin Kate Kelley, Lorenza Rimassa, Ann-Lii Cheng, et al.
Communications Biology
|
June 6, 2022
GDAP1 loss of function inhibits the mitochondrial pyruvate dehydrogenase complex by altering the actin cytoskeleton
Christina Wolf, Alireza Pouya, Sara Bitar, et al.
Cell Reports
|
March 11, 2025
Unveiling IRF4-steered regulation of context-dependent effector programs in CD4<sup>+</sup> T cells under Th17- and Treg-skewing conditions
Anna Gabele, Maximilian Sprang, Mert Cihan, et al.
Page
of 50
Search research articles
Search
Showing results (421-430 of 493) with videos related to
Sort By:
Page
of 50
Genome Medicine
|
November 24, 2016
High-specificity bioinformatics framework for epigenomic profiling of discordant twins reveals specific and shared markers for ACPA and ACPA-positive rheumatoid arthritis
David Gomez-Cabrero, Malin Almgren, Louise K Sjöholm, et al.
Journal of Proteome Research
|
February 7, 2025
TIMS<sup>2</sup>Rescore: A Data Dependent Acquisition-Parallel Accumulation and Serial Fragmentation-Optimized Data-Driven Rescoring Pipeline Based on MS<sup>2</sup>Rescore
Arthur Declercq, Robbe Devreese, Jonas Scheid, et al.
Haematologica
|
April 6, 2023
Gene therapy restores the transcriptional program of hematopoietic stem cells in Fanconi anemia
Miren Lasaga, Paula Río, Amaia Vilas-Zornoza, et al.
Journal of Geriatric Oncology
|
November 30, 2024
Real-world data on the clinical features, therapy patterns, and outcomes of older adults with diffuse large B-cell lymphoma in Latin America: A study from the Grupo de Estudio Latinoamericano de Linfoproliferativos (GELL)
Myrna Candelaria, Luis Villela, Luis F Oñate-Ocana, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie
|
May 11, 2022
Resuscitative endovascular balloon occlusion of the aorta in Canada: a context-specific position paper from the Canadian Collaborative for Urgent Care Surgery (CANUCS)
Nori L Bradley, W Robert Leeper, Derek Roberts, et al.
Molecular Pharmacology
|
February 20, 2016
Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model
Shannon Dallas, Laurent Salphati, David Gomez-Zepeda, et al.
The Lancet. Gastroenterology & Hepatology
|
February 16, 2024
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study
Thomas Yau, Ahmed Kaseb, Ann-Lii Cheng, et al.
The Lancet. Oncology
|
July 7, 2022
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial
Robin Kate Kelley, Lorenza Rimassa, Ann-Lii Cheng, et al.
Communications Biology
|
June 6, 2022
GDAP1 loss of function inhibits the mitochondrial pyruvate dehydrogenase complex by altering the actin cytoskeleton
Christina Wolf, Alireza Pouya, Sara Bitar, et al.
Cell Reports
|
March 11, 2025
Unveiling IRF4-steered regulation of context-dependent effector programs in CD4<sup>+</sup> T cells under Th17- and Treg-skewing conditions
Anna Gabele, Maximilian Sprang, Mert Cihan, et al.
Page
of 50